Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5630292 | Journal of Neuroimmunology | 2016 | 8 Pages |
â¢MOG61-85 represents a cryptic epitope of rMOG in wild-type C57BL/6 mice.â¢MOG61-85 is naturally processed in B cell-deficient C57BL/6 mice.â¢Immunization with MOG35-55 + MOG61-85 ameliorates clinical EAE in B cell â/â miceâ¢Processing of MOG61-85 is regulated by an antibody-dependent mechanism
Previous work demonstrated that EAE induced by recombinant human MOG was B cell-dependent. Data presented here reveal a T cell response to MOG61-85 in human rMOG-immunized B cellâ/â mice not observed in WT mice. Further study revealed this peptide to be a cryptic epitope in WT mice. Co-immunization of B cellâ/â mice with MOG35-55 and MOG61-85 peptides led to less severe disease compared to mice immunized with MOG35-55 alone. Disease amelioration was associated with decreased production of Interferon-γ by lymph node cells. Thus, MOG61-85 represents a protective epitope to human rMOG induced EAE in B cellâ/â mice.
Graphical abstractDownload high-res image (163KB)Download full-size image